OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 60 filers reported holding OYSTER PT PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $469,000 | -57.0% | 40,326 | -32.5% | 0.05% | -43.5% |
| Q4 2021 | $1,091,000 | +43.0% | 59,752 | -7.1% | 0.09% | +37.3% |
| Q3 2021 | $763,000 | -32.8% | 64,342 | -2.7% | 0.07% | -32.3% |
| Q2 2021 | $1,136,000 | -15.3% | 66,098 | -9.9% | 0.10% | -20.8% |
| Q1 2021 | $1,341,000 | -0.8% | 73,361 | +2.1% | 0.12% | +5.0% |
| Q4 2020 | $1,352,000 | -28.8% | 71,865 | -20.1% | 0.12% | -19.6% |
| Q3 2020 | $1,900,000 | -32.5% | 89,991 | -7.6% | 0.15% | -37.3% |
| Q2 2020 | $2,814,000 | – | 97,426 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 2,768,586 | $32,226,000 | 14.34% |
| Paradigm Biocapital Advisors LP | 987,698 | $11,497,000 | 3.04% |
| NEA Management Company, LLC | 5,925,287 | $68,970,000 | 1.99% |
| KPCB XIV Associates, LLC | 367,987 | $4,283,000 | 1.61% |
| Telemark Asset Management, LLC | 787,026 | $9,161,000 | 0.81% |
| COWEN AND COMPANY, LLC | 509,794 | $5,934,000 | 0.57% |
| RTW INVESTMENTS, LP | 2,058,504 | $23,961,000 | 0.50% |
| ACT CAPITAL MANAGEMENT, LLC | 13,500 | $157,000 | 0.17% |
| Kohlberg Kravis Roberts & Co. L.P. | 1,039,622 | $12,101,000 | 0.11% |
| Wildcat Capital Management, LLC | 36,847 | $429,000 | 0.11% |